Bucheon, South Korea

Il-Hee Cho

This inventor holds 1 USPTO granted patent. Top assignee: Firson. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Il-Hee Cho. Retrieved from https://idiyas.com/inventor/il-hee-cho-sz26i6wd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Il-Hee Cho: Innovator in Pharmaceutical Synthesis

Introduction

Il-Hee Cho is a notable inventor based in Bucheon-si, South Korea. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of methods that enhance the purity and yield of important medicinal compounds.

Latest Patents

Il-Hee Cho holds a patent for a synthesis method aimed at improving tenofovir disoproxil fumarate (Teno-DF). This compound is crucial in the treatment of hepatitis B and HIV due to its bioactive properties. The patented method utilizes an ion-exchange resin, specifically Dowex 50W in hydrogen form, to prevent the formation of impurities and byproducts during synthesis. Additionally, the invention includes a method for preparing an oral dissolving film dosage form using the high-purity tenofovir compound obtained through this synthesis method.

Career Highlights

Il-Hee Cho is associated with Firson, where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficiency and effectiveness of drug formulations, contributing to better treatment options for patients.

Collaborations

Il-Hee Cho has collaborated with notable colleagues, including Dong-Jin Kim and Chang-Hui Koo. Their combined expertise has furthered advancements in pharmaceutical research and development.

Conclusion

Il-Hee Cho's innovative work in the synthesis of tenofovir disoproxil fumarate exemplifies the impact of scientific research on medicine. His contributions are vital for improving treatment methodologies for serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…